You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

GSK2118436

Showing 1 - 25 of 47
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the CNS

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +3 more
  • Scottsdale, Arizona
  • +2 more
Jan 4, 2023

BRAF NP_004324.2:p.V600E, BRAF V600K Mutation Present, Thyroid Gland Anaplastic Carcinoma Trial in Duarte, Columbus (Dabrafenib,

Recruiting
  • BRAF NP_004324.2:p.V600E
  • +2 more
  • Duarte, California
  • +1 more
Jan 19, 2023

Thyroid Gland Anaplastic Carcinoma, Thyroid Gland Squamous Cell Carcinoma Trial in Houston, Salt Lake City (procedure, drug,

Recruiting
  • Thyroid Gland Anaplastic Carcinoma
  • Thyroid Gland Squamous Cell Carcinoma
  • Conventional Surgery
  • +5 more
  • Stanford, California
  • +5 more
Jan 26, 2023

Pathologic Stage IIIB Cutaneous Melanoma AJCC v8, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8, Pathologic Stage IIID

Active, not recruiting
  • Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 9, 2022

BRAF V600E Mutation Present, BRAF V600K Mutation Present, Metastatic Malignant Solid Tumor Trial in Boston (Dabrafenib,

Active, not recruiting
  • BRAF V600E Mutation Present
  • +9 more
  • Boston, Massachusetts
  • +1 more
Jun 28, 2022

BRAF V600E Mutation Present, BRAF V600K Mutation Present, Metastatic Melanoma Trial in Boston (drug, biological, other)

Terminated
  • BRAF V600E Mutation Present
  • +7 more
  • Boston, Massachusetts
  • +1 more
Mar 9, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in United States (Dabrafenib Mesylate, Tazemetostat

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • Metastatic Melanoma
  • Dabrafenib Mesylate
  • +2 more
  • Atlanta, Georgia
  • +6 more
Nov 30, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Melanoma, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 Trial

Active, not recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +4 more
  • Dabrafenib Mesylate
  • +3 more
  • Philadelphia, Pennsylvania
    Perelman Center for Advanced Medicine
Dec 29, 2021

Thyroid Gland Anaplastic Carcinoma Trial in Saint Petersburg (Dabrafenib, Trametinib)

Recruiting
  • Thyroid Gland Anaplastic Carcinoma
  • Saint Petersburg, Russian Federation
    Saint-Petersburg State University (SPSU) N.I.Pirogov Clinic of H
Feb 3, 2021

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Malignant Solid Tumor Trial in

Active, not recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +4 more
  • Phoenix, Arizona
  • +48 more
Jan 3, 2023

Cancer Trial in Worldwide (Dabrafenib, Trametinib, Panitumumab)

Completed
Has Results
  • Cancer
  • Scottsdale, Arizona
  • +19 more
Sep 30, 2021

Erdheim-Chester Disease Trial in Houston (Dabrafenib Mesylate, Quality-of-Life Assessment, Questionnaire Administration)

Withdrawn
  • Erdheim-Chester Disease
  • Dabrafenib Mesylate
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 16, 2021

Melanoma Trial in New York (Dabrafenib)

Completed
Has Results
  • Melanoma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 8, 2020

Stage III Melanoma, Stage IV Melanoma, Unresectable Melanoma Trial in Chapel Hill (BRAF inhibitor dabrafenib and MEK inhibitor

Completed
Has Results
  • Stage III Melanoma
  • +3 more
  • BRAF inhibitor dabrafenib and MEK inhibitor trametinib
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center, University of North Caro
Nov 3, 2020

Ameloblastoma, BRAF Gene Mutation Trial in Stanford (Dabrafenib, Trametinib)

Completed
Has Results
  • Ameloblastoma
  • BRAF Gene Mutation
  • Stanford, California
    Stanford University, School of Medicine
Jan 17, 2020

Cancer Trial in Worldwide (Dabrafenib, Trametinib)

Completed
  • Cancer
  • Little Rock, Arkansas
  • +51 more
Jun 8, 2022

Cancer Trial in Worldwide (Dabrafenib, Trametinib)

Completed
Has Results
  • Cancer
  • Los Angeles, California
  • +49 more
Apr 1, 2022

Cancer Trial in Australia, United States (GSK2118436, GSK1120212)

Completed
Has Results
  • Cancer
  • Los Angeles, California
  • +14 more
Jun 25, 2019

Melanoma Trial in Worldwide (Dabrafenib, Trametinib, Placebos)

Active, not recruiting
Has Results
  • Melanoma
  • Birmingham, Alabama
  • +209 more
Nov 14, 2022

Solid Tumor Trial in Columbus, Houston (dabrafenib, pazopanib HCl, Correlative studies)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • Columbus, Ohio
  • +1 more
Feb 28, 2019

Cancer Trial in Worldwide (GSK2118436, GSK1120212, Other approved anti-cancer agent)

Completed
  • Cancer
  • GSK2118436
  • +2 more
  • Goodyear, Arizona
  • +43 more
Mar 20, 2019

Melanoma Trial in Worldwide (Dabrafenib, Vemurafenib, Trametinib)

Completed
Has Results
  • Melanoma
  • Birmingham, Alabama
  • +204 more
Feb 8, 2021

Melanoma Trial in Worldwide (Dabrafenib, Trametinib, Trametinib )

Completed
Has Results
  • Melanoma
  • Scottsdale, Arizona
  • +120 more
Feb 8, 2021

BRAF Gene Mutation, Hepatic Complication, Renal Failure Trial in Canada, United States (Dabrafenib, Laboratory Biomarker

Terminated
  • BRAF Gene Mutation
  • +3 more
  • Duarte, California
  • +17 more
Aug 13, 2018

Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1429 more
Aug 17, 2022